This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

Individualized predictions of disease progression following radiation therapy for prostate cancer

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Jeremy Taylor (University of Michigan)
Menggang Yu (University of Michigan)
Howard Sandler (University of Michigan Radiation Oncology)
Abstract

Background: Following treatment for localized prostate cancer, men are monitored with serial PSA measurements. Refining the predictive value of post-treatment PSA determinations may add to clinical management and we have developed a model that predicts for an individual patient future PSA values and estimates the time to future clinical recurrence.Methods: Data from 934 patients treated for prostate cancer between 1987 and 2000 were used to develop a comprehensive statistical model to fit the clinical recurrence events and pattern of PSA data. A logistic regression model was used for the probability of cure, non-linear hierarchical mixed models were used for serial PSA measurements and a time-dependent proportional hazards model was used for recurrences. Data available up to February 2001 and September 2003 was used to assess the performance of the model.Results: The model suggests that T-stage, baseline PSA, and radiotherapy dosage are all associated with probability of cure. The risk of clinical recurrence in those not cured by radiotherapy is most strongly affected by the slope of the long-transformed PSA values. We show how the model can be used for individual monitoring of a patient's disease progression. For each patient the model predicts, based upon his baseline and all post-treatment PSA values, the probability of future clinical recurrence in the validation dataset and of 406 PSA measurements obtained 1-2 years after February 2001, 92.8% were within 95% prediction limits from the model.Conclusions: This statistical model presented accurately predicts future PSA values and risk of clinical relapse. This predictive information for each individual patient, which can be updated with each additional PSA value, may prove useful to patents and physicians in determining what post-treatment salvage should be employed.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.bepress.com/cgi/viewcontent.cgi?article=1024&context=umichbiostat
File Format: application/pdf
File Function:
Download Restriction: no

Publisher Info
Paper provided by Berkeley Electronic Press in its series The University of Michigan Department of Biostatistics Working Paper Series with number 1024.

Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
Length:
Date of creation: 11 Jul 2004
Date of revision:
Handle: RePEc:bep:mchbio:1024

Note: oai:bepress.com:umichbiostat-1024
Contact details of provider:
Web page: http://www.bepress.com

For technical questions regarding this item, or to correct its listing, contact: (Christopher F. Baum).

Related research
Keywords: prostate cancer; PSA slope; biochemical recurrence; clinical recurrence; joing longitudinal-survival models.;

Statistics
Access and download statistics

Did you know? Over 1000 institutions contribute their bibliographic data directly to this service.

This page was last updated on 2009-12-15.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.